Navigation Links
Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide

e="float:right; position: relative;">

"We are pleased that these results complement our previous study with linaclotide in patients suffering from chronic constipation," said Mark Currie, Ph.D., Microbia's senior vice president of research and development. "These data greatly expand our understanding of the potential beneficial actions of linaclotide in patients with lower bowel dysfunction and provide an impetus to advance this agent in later stage clinical development."

About Linaclotide

Linaclotide is a first-in-class compound currently being tested for the treatment of IBS-C, CC and other gastrointestinal disorders. Linaclotide is an agonist of guanylate cyclase type-C, a receptor found on the lining of the intestine. In preclinical testing linaclotide was shown to increase fluid secretion into the intestine, accelerate intestinal transit, and decrease visceral pain. Linaclotide was designed to exert its effect on the intestine with minimal systemic exposure. In Phase 1 testing linaclotide was well tolerated and was not detected in the systemic circulation of healthy subjects. Linaclotide is currently being studied in a pair of Phase 2 dose- ranging trials for IBS-C and CC.

About Irritable Bowel Syndrome (IBS)

One out of six adults in developed countries suffers from IBS, a chronic condition marked by abdominal pain and disturbed bowel function. Patients with IBS often have altered patterns of gastrointestinal motility which contribute to symptoms. Colonic transit that is too rapid results in diarrhea, while delayed colonic transit results in constipation. IBS accounts for 12% of adult visits to primary care physicians and is the most common disorder diagnosed by gastroenterologists. Health care costs associated with IBS exceed $25 billion annually. IBS patients fall into three subgroups-constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and alternating (IBS-A)-and 30% to 40% of these patients suffer from IBS-C.
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- United Medical ... Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS) ... PALS, BLS and ACLS online course manuals. ... people simply need to build an account with the ... for these programs, United Medical Education is setting a ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group has ... their competitive landscape map for the Chronic Kidney ... 90 international companies with drugs and devices currently ... and its sequelae. (Logo:  ... , hypertension - renal denervation , ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The escalation ... proteins, is placing renewed emphasis on alternate delivery ... as a number of factors are converging to ... makers and their delivery device partners . These ... conditions, the growing trend toward self-administration for chronic ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... STATEN ISLAND, N.Y., Feb. 28, 2011  A 67-year-old man ... his wife after wandering outside in near-freezing temperatures thanks to ... a watch-like EmSeeQ® wearable locator device. ... Marilyn, discovered him missing. He was located on Victory Boulevard, ...
... Corporation (Nasdaq: HSKA ; "Heska" or the ... Thursday, March 3rd, 2011.  The company,s presentation is scheduled ... Mountain Time) and is to be available to interested ... is to be available via live webcast and for ...
Cached Medicine Technology:Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3Heska to Present Live, Online at RetailInvestorConferences.com 2
(Date:5/19/2013)... 2013 Healthcare leaders will gather at ... the Walt Disney World Swan and Dolphin in Orlando, ... innovation, care delivery and healthcare reform and implementation. , ... healthcare markets, with consolidation, efficiency and reduced ... Todd Ebert, Amerinet president and CEO. “There is a ...
(Date:5/19/2013)... The muscles in the human body are ... of the biggest and most significant nervous systems in ... system comprises of peripheral nerves that reside outside of ... that the limbs and hands, as well as other ... damaged due to trauma or physical injury, their functionality ...
(Date:5/19/2013)... These molecular diagnostics market reports provide ... Italy, Germany and France:,     Major ... as well as key economic, regulatory, demographic, social ... the next five years. ,     An extensive ... formats, detection methodologies, trends in testing automation and ...
(Date:5/19/2013)... Denver, Colorado (PRWEB) May 19, 2013 ... the first seed in the ground 10,000 years ago. ... dramatically increased farm productivity by using genetically engineered seeds ... are now seeing a backlash to these techniques due ... technologies and chemicals and a corresponding surge in interest ...
(Date:5/19/2013)... 2013 Agora Health Limited developed by Rachael ... on how to increase memory power naturally and ... that helps people re-new their entire health from the inside ... caused by a fatigued mind. In addition, the program helps ... a lifetime. The author claimed that this program can help ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2
... N.C., Oct. 19 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... split. The vote was part of a general meeting in ... to the company board of directors. , At the meeting, ... formal launch of the company,s Dermacyte(TM) Oxygen Concentrate Gel for ...
... Offer Vital Information for Adults, Children in English, Spanish ... preparations for the H1N1 flu season kick into high ... education and media campaign. , The California Hospital Association ... (PSAs) aimed at educating all Californians about the signs ...
... PICK: The protein APC slows Lou Gehrig,s disease in ... known as Lou Gehrig,s disease, is a neurodegenerative disease ... largely palliative. Using mice carrying the mutated form of ... ALS, however, Berislav Zlokovic and colleagues, at the University ...
... study needed to see if medical treatment cuts rates ... (HealthDay News) -- Children with attention-deficit/hyperactivity disorder (ADHD) are ... activity when they grow older, a U.S. study has ... who were later surveyed in adulthood. It found that ...
... see many patients daily may be key players in ... Hospital workers who see many patients may play a ... study finds. , These so-called peripatetic workers, such as ... course of a day, said Laura Temime, a researcher ...
... go after users or suppliers in states that permit use ... The Obama administration has decided it will no longer prosecute ... of states that allow use of the drug for medicinal ... in a Justice Department memo to federal prosecutors on Monday, ...
Cached Medicine News:Health News:Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split 2Health News:Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split 3Health News:California Hospitals Launch H1N1 Public Service Announcement Campaign 2Health News:JCI table of contents: Oct. 19, 2009 2Health News:JCI table of contents: Oct. 19, 2009 3Health News:Childhood ADHD Linked to Criminal Behavior in Adults 2Health News:Hospital Workers May Trigger Dangerous Outbreaks 2Health News:Hospital Workers May Trigger Dangerous Outbreaks 3Health News:U.S. Relaxes Opposition to Medical Marijuana 2Health News:U.S. Relaxes Opposition to Medical Marijuana 3
Bravo Tubing/Filter Supplies (Ten tubing sets, ten filters)...
Stand with buffer tubes for calibration of Bravo pH capsule....
Bravo pH capsule with delivery system....
The pouch is designed to protect the Digitrapper. The pouch strap can be worn on a belt loop or carried in a shoulder strap or backpack configuration....
Medicine Products: